Table 2.
Univariate logistic regression analysis for the presence of CAD.
| OR | 95%CI | P | |
|---|---|---|---|
| Male sex | 4.27 | 1.78 – 11.2 | 0.001 |
| Age (per year) | 1.00 | 0.97 - 1.03 | 0.96 |
| Body mass index ≥30 kg/m2 | 1.31 | 0.64 – 2.72 | 0.46 |
| Current smoking (yes) | 3.23 | 1.14 – 10.6 | 0.03 |
| Hypertension (yes) | 1.31 | 0.63 – 2.74 | 0.47 |
| Diabetes (yes) | 4.02 | 1.54 – 11.9 | 0.004 |
| Systolic blood pressure (per mmHg) | 0.98 | 0.96 – 1.00 | 0.09 |
| Diastolic blood pressure (per mmHg) | 1.00 | 0.96 – 1.04 | 0.97 |
| Fasting blood glucose (per mg/dl) | 1.02 | 1.01 – 1.04 | 0.004 |
| Total cholesterol (per mg/dl) | 1.01 | 1.00 – 1.02 | 0.19 |
| HDL cholesterol (per mg/dl) | 0.95 | 0.92 – 0.98 | <0.001 |
| Triglycerides (per mg/dl) | 1.01 | 1.00 – 1.01 | 0.02 |
| Aspirin (yes) | 2.57 | 1.20 – 5.64 | 0.01 |
| Statins (yes) | 1.61 | 0.78 – 3.36 | 0.20 |
| Beta blockers (yes) | 1.78 | 0.85 – 3.77 | 0.13 |
| ACE-I or ARB (yes) | 1.47 | 0.69 – 3.13 | 0.32 |
| Nitrate (yes) | 0.77 | 0.30 – 1.94 | 0.57 |
| Anti-diabetic drugs (yes) | 2.64 | 0.97 – 7.97 | 0.06 |
| 10 years FRS (per %) | 1.08 | 1.03 - 1.14 | <0.001 |
| Ln_RHI (per 0.1 decrease) | 1.30 | 1.12 – 1.54 | <0.001 |
ACE-I: angiotensin-converting enzyme-inhibitors, ARB: angiotensin II receptor blockers, CAD: coronary artery disease, CI: confidence interval, FRS: Framingham Risk Score, HDL: high density lipoprotein, OR odds ratio, and RHI: reactive hyperemia-peripheral arterial tonometry index.